IDiyas

For the Inventor, By the Inventor

Stockholm, Sweden

Lars Johansson

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 6.5

ph-index = 5

Forward Citations = 123(Granted Patents)


Location History:

  • 611 45 Nykoping, SE (1987)
  • Stockholm, SE (2007 - 2014)
  • Saltsjö-Boo, SE (2018)
  • Bromma, SE (2010 - 2022)

Company Filing History:

goldMedal5 out of 1,970 
 
Amgen Inc.
 patents
silverMedal4 out of 55 
 
Biovitrum Ab
 patents
bronzeMedal1 out of 1 
 
Genase Therapeutics B.v.
 patent
4. 1 out of 1 
 
Northcone Ab
 patent
5. 1 out of 4 
 
Lu License Ab
 patents
6. 2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1987-2022

where 'Filed Patents' based on already Granted Patents

10 patents (USPTO):
1. 11471446 - Compounds for treatment of hypoproliferative disorders (2022-10-18),
2. 10889564 - Tetrahydroindazoles and medical uses thereof (2021-01-12),
3. 9869107 - Pole arrangement (2018-01-16),
4. 8686011 - Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 (2014-04-01),
5. 8541592 - Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (2013-09-24),
6. 7807700 - Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 (2010-10-05),
7. 7666888 - Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1 (2010-02-23),
8. 7253196 - Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 (2007-08-07),
9. 4714025 - Arrangement for a switchboard desk (1987-12-22),
10. 4711184 - Arrangement for a desk comprising a desk-top which can be raised and (1987-12-08),

Title: Lars Johansson: Pioneering Innovations in Medicine and Technology

Introduction:

Lars Johansson, a visionary inventor based in Stockholm, SE, has left an indelible mark on the world of medicine and technology. With a passion for innovation and a relentless pursuit of excellence, Johansson continues to inspire the next generation of inventors and shape the future of technology.

Latest Patents:

Johansson's innovative spirit is evident in his latest patents. One of his groundbreaking inventions includes compounds for the treatment of hypoproliferative disorders. This invention focuses on the use of CDK8 and/or CDK19 inhibitors in the treatment of ribosomopathies, conditions characterized by a reduced number of hematopoietic stem cells, progenitor cells, and bone anabolic disorders. Additionally, Johansson has patented tetrahydroindazoles and their medical uses for the treatment of cancer and/or the prevention of viral infections.

Career Highlights:

Throughout his illustrious career, Johansson has worked with prestigious companies such as Amgen Inc. and Biovitrum Ab. His innovative mindset and dedication to pushing boundaries have led to the development of life-changing technologies in the field of medicine and beyond.

Collaborations:

Johansson's collaborative efforts with industry experts like Michael D Bartberger and Christopher Harold Fotsch have paved the way for groundbreaking discoveries and advancements in the realm of science and technology. Together, they have contributed significantly to the innovation landscape, fostering a culture of creativity and exploration.

Conclusion:

In conclusion, Lars Johansson's pioneering spirit and commitment to innovation have positioned him as a trailblazer in the world of inventions. His contributions to medicine and technology continue to inspire and drive progress in the field, setting the stage for a future defined by cutting-edge advancements and transformative breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…